Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.9 USD | -1.30% | +2.58% | 0.00% |
Apr. 30 | Morgan Stanley Starts Contineum Therapeutics With Overweight Rating | MT |
Apr. 30 | Stifel Starts Contineum Therapeutics With Buy Rating, $29 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 405M | |
+67.48% | 62.86B | |
-1.10% | 41.38B | |
+46.00% | 40.38B | |
-10.72% | 27.64B | |
+14.31% | 26.46B | |
-22.20% | 18.9B | |
+3.99% | 12.67B | |
+23.87% | 12.27B | |
+28.86% | 12.07B |
- Stock Market
- Equities
- CTNM Stock
- News Contineum Therapeutics, Inc.
- RBC Initiates Contineum Therapeutics at Outperform, Speculative Risk With $30 Price Target